Femoston Conti

Femoston Conti

estradiol + dydrogesterone

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Estradiol 1 mg, dydrogesterone 5 mg
Indications/Uses
HRT for the relief of symptoms due to estrogen deficiency in women w/ uterus. Prevention of postmenopausal osteoporosis in women w/ uterus.
Administration
May be taken with or without food.
Contraindications
Confirmed active VTE, history or recurrent VTE, active or recent arterial thromboembolic disease, breast cancer, endometrial carcinoma or other hormone-dependent tumors. CVA, undiagnosed vag bleeding.
Special Precautions
Periodic check-ups are recommended. Risk factors for VTE. History of thromboembolic disorders, otosclerosis, multiple sclerosis, SLE, porphyria, melanoma, epilepsy, migraine, asthma, liver disease, endometriosis, uterine fibroids, HTN, cardiac or renal dysfunction & haemoglobinopathies. Diabetic patients. Pregnancy & lactation.
Adverse Reactions
GUT systems, breast tenderness & enlargement, nausea, vomiting, abdominal cramps, bloating, cholestatic jaundice, chloasma or melasma, steepening of corneal curvatures, intolerance to contact lenses, CNS disturbances.
Drug Interactions
Oxcarbazepine, topiramate, felbamate, barbiturates, phenytoin, rifampicin, carbamazepine.
MIMS Class
Oestrogens, Progesterones & Related Synthetic Drugs
ATC Classification
G03CA03 - estradiol ; Belongs to the class of natural and semisynthetic estrogens used in estrogenic hormone preparations.
Presentation/Packing
Form
Femoston Conti film-coated tab
Packing/Price
28's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in